Alex
At Best Startup Canada we track over 100,000 Canadian startups and over 500,000 people who hold key positions in these companies. We use this directory of startups to highlight top employees, founders and board members we think deserve more appreciation than they are currently getting.
This list showcases the top British Columbia based CEO’ operating in the Health Care space. If you think a CEO’ is missing from this list, feel free to contact our editor on editor@beststartup.ca.
The individuals on this list have been included because of exceptional performance in one of the following categories:
- Innovation – Operating as a key part in an extremely innovative business or startup.
- Growth – Operating as a key figure in the growth and upscale of a market leading business or startup.
- Management – Showing exceptional management skills.
- Societal impact – Putting their business on the map for their positive societal or environmental impact.
Our Data – We source our data from OSINT (open source intelligence) and public directories such as Crunchbase, SemRush and many more. The data from these sources should be treated with a degree of caution and verified yourself.
Landon Hamilton
Co-Founder/CEO of Fitplan
CEO of Fitplan
Follow Landon Hamilton:
About Fitplan, Total Fitness and Nutrition: A mobile fitness app with interactive training programs world’s best personal trainers at your fingertips – anytime, anywhere.
Andrew Ahachinsky
CEO of Eterly
Andrew is a passionate longevity advocate and life science evangelist with background in mobile and software development. Andrew has been involved in several AI based life science projects aiming at optimizing lifestyle factors and biomarkers.
Follow Andrew Ahachinsky:
About Eterly: Revolutionary artificial intelligence app for life extension
Michael Fergusson
Founder & CEO of Ayogo Health
Michael has raced giraffes, terraformed a planet, and hunted vampires, and that was just this morning! He learned to touch type by hunting sharks, and has travelled the entire Oregon Trail without getting scurvy. He also believes that playing is one of the most meaningful and productive things we can do. Michael is the CEO and Founder of Ayogo, a company that has won many awards for their use of game psychology and social networks to help patients take control of their treatments. For this work, Michael was Ernst & Young’s Social Entrepreneur of the Year, and was recently named to the PharmaVOICE 100, a peer-nominated list of the 100 most inspiring people in Life Sciences. Michael has been a multi-gold medalist and grand champion at the Western Canadian Martial Arts Championships and lives in Vancouver with his family.
Follow Michael Fergusson:
About Ayogo Health, Viospatia: Ayogo is a Vancouver-based digital health company .
Aneil Manhas
Founder & CEO of Bruush
Follow Aneil Manhas:
About Bruush: Keep your teeth healthy and white with Brüush – a premium electric toothbrush subscription with a luxury look and feel
Patrick L McGeer
Founder,President & CEO of Aurin Biotech
Dr. Patrick McGeer is a professor emeritus in the Faculty of Medicine at the University of British Columbia (UBC). He received his PhD in chemistry at Princeton University and his MD at UBC. In between he worked for the DuPont Company in Wilmington, Delaware where he met his wife, Dr. Edith McGeer. Dr. McGeer is a fellow of the American Association for the Advancement of Science, the Royal Society of Canada and the Royal College of Physicians and Surgeons of Canada. He is an Officer of the Order of Canada and a member of the Order of British Columbia. He has repeatedly served on scientific review panels for the National Institutes of Health (NIH) and on advisory boards for the Dystonia Medical Research Foundation and the Canadian societies for Parkinson’s disease, ALS and multiple sclerosis. For many years, he combined his scientific career with politics, serving in the British Columbia Legislature from 1962 to 1986, and in the British Columbia Cabinet from 1975 to 1986. In Government, he worked to promote the development of high technology industry in the province, and also served as President and Chairman of the Board of the Insurance Corporation of British Columbia, and on the Board of the British Columbia Hydro and Power authority, The British Columbia Petroleum Corporation, and the British Columbia Systems Corporation. He is the Founder of two charitable foundations, the Pacific Alzheimer Research Foundation, and the Canadian Dementia Action Network. Dr. McGeer is the author of more than 680 scientific papers and 8 patents. With his wife Edith and Nobel Laureate Sir John Eccles, he is an author of two scientific textbooks and is the editor of 3 others. Dr. McGeer is the recipient of four honorary degrees and is recognized as one of the world’s most highly cited neuroscientists.
Follow Patrick L McGeer:
About Aurin Biotech: Aurin Biotech Inc. is a private company established to advance the development of a remarkable collection of small molecules.
Tamer Mohamed
Founder & CEO of Aspect Biosystems
A bioengineer, inventor, and entrepreneur, Tamer currently serves as President and CEO of Aspect Biosystems. The company is tackling some of the biggest challenges in medicine by enabling the 3D printing of living human tissues. Tamer co-founded Aspect in 2013 and has played a leading role in overall corporate, business, and technology development. As a leader and visionary in the field of regenerative medicine and 3D printing, he has been invited to speak on this topic at venues ranging from TEDx to industry, scientific and executive conferences. He was awarded with BC’s Top 30 under 30 award for demonstrating excellence in business, judgement, leadership, and community contribution. Tamer serves on the Board of Directors of ACETECH, a non-profit training and mentoring organization for CEOs of technology and life sciences companies, and on the Board of Directors of The Stem Cell Network, an organization focused on building Canada’s stem cell and regenerative medicine research sector.
Follow Tamer Mohamed:
About Aspect Biosystems: Biotech company combining the power of microfluidics & 3D bioprinting to fuel medical research and development of bioprinted therapeutics
Richard Zwicky
Chief Executive Officer and Founder of Plena
Richard founded Plena Global in 2017 to organize the world’s medical cannabis trade and ensure patients have access to the medications they need. Prior to founding Plena, Richard was founder and President of analytics company Enquisite, founder of digital marketing company Metamend Software & Design Ltd., where he remains Chairman, and entrepreneur-in-residence at the University of Victoria’s Gustavson School of Business. Richard holds a B.A. from McGill University.
Follow Richard Zwicky:
About Plena: Plena is a holding company based in Canada with a focus on large-scale production of high-grade medical cannabis.
Sandra Dunn
CEO and Founder of Phoenix Molecular Designs
Dr. Sandra Dunn founded Phoenix Molecular Designs in 2012, following the identification of a novel approach to treating TNBC, the deadliest form of breast cancer. The discovery of RSK as a prime target for TNBC came from functional genomic screens in her laboratory. Dr. Dunn has spent more than 27 years as a breast cancer researcher and as such has served on multiple oversight committees, including: Canadian Breast Cancer Foundation, Department of Defense Breast Cancer Research Program (USA) and the Susan Komen Foundation. She was the youngest member of the DOD Breast Cancer Research Program in the early 1990s and was recognized for her commitment to the field during her early days as a postdoctoral fellow at the National Institutes of Health. Dr. Sandra Dunn is passionate about making a difference in the lives of people suffering from cancer and is firmly dedicated to breast cancer. This was inspired by personal experiences with the disease in her family, as it impacted several generations of women. Her broad range of experience in private industry, government and academia has prepared her to lead PhoenixMD, where they are working to change the outcomes for women with breast cancer by developing a selective new drug to uniquely attack the cancer cells in a way that has not been done before. She has led multinational oncology research projects to advance the development of novel cancer therapeutics and has built amazing teams to achieve these goals. Over the past three decades, she has raised millions of dollars to fund cancer research and has built one of the few female-led biotechnology companies specifically aimed at eradicating breast cancer. Dr. Sandra Dunn is technology leader in oncology drug development and biotechnology businesses
Follow Sandra Dunn:
About Phoenix Molecular Designs: Phoenix Molecular Designs is a biopharmaceutical company designing precise cancer therapeutics by targeting kinases.
Jeffrey Bacha
President & CEO/cofounder of Kintara Therapeutics
Jeffrey Bacha, BSc, MBA co-founded DelMar Pharmaceuticals in 2010 and has served as Chief Executive Officer and Chairman of the Company’s board of directors since inception. Mr. Bacha is a seasoned executive leader with nearly twenty years of life sciences experience in the areas of operations, strategy and finance. His background includes successful public and private company building from both a start-up and turn around perspective; establishing and leading thriving management and technical teams; and raising capital in both the public and private markets. From July 2006 to August 2009, Mr. Bacha was Executive Vice President Corporate Affairs and Chief Operating Officer at Clera, Inc. From March 2005 to July 2006 Mr. Bacha was Consultant and held various positions at Clera Inc., Urigen Holdings Inc. and XBiotech, Inc. From 1999 through 2004, Mr. Bacha served as President & CEO of Inimex Pharmaceuticals, a venture-capital funded drug discovery and development company and is a former Senior Manager and Director of KPMG Health Ventures. Mr. Bacha holds an MBA from the Goizueta Business School at Emory University and a degree in BioPhysics from the University of California, San Diego.
Follow Jeffrey Bacha:
About Kintara Therapeutics: Kintara Therapeutics is engaged in developing and commercializing therapies for the treatment of cancer patients.
Raj Gulia
Co-founder & CEO of PocketPills
Raj Gulia is a Co-Founder at PocketPills.
Follow Raj Gulia:
About PocketPills: Pocketpills is Canada’s leading online pharmacy, delivers medication by the dose, straight to customer’s door.
Fahar Merchant
President and CEO of Medicenna Therapeutics
Fahar Merchant is a 25-year biotech veteran, a serial entrepreneur and co-founder of Medicenna. Previously he was President and CEO of Protox Therapeutics (TSX.V and TSX; now Sophiris Bio, Nasdaq) where he established a late clinical stage urology company. At Protox he raised more than $70M through multiple PIPEs, including a $35M investment by Warburg Pincus. In 1992 he co-founded IntelliGene Expressions, Inc., a biologics CDMO, and built it to one of the fastest growing companies in Canada. In 2000, by strategic in-licensing, he co-founded Avicenna Medica, Inc., a clinical stage oncology company that was sold a year later to KS Biomedix (LSE) for $90M. Fahar was CTO and Director of KS Biomedix until its acquisition by Xenova (Nasdaq and LSE; now Celtic Pharma). Fahar has closed several transactions valued at more than $300M. He has a PhD in Biochemical Engineering from Western University.
Follow Fahar Merchant:
About Medicenna Therapeutics: Medicenna is a clinical stage, privately held, immuno-oncology company.
Carolyn Cross
Founder, Chairman & Chief Executive Officer of Ondine Biomedical
Ms. Cross was one of the initial founders and financial supporters of Ondine Biomedical Inc. in 1999 and currently serves as the Chairman of the board and Chief Executive Officer the Company. Ms. Cross has over 18 years direct experience working with early stage companies and has 25 years experience with public market securities. Previously, Ms. Cross was responsible for managing pension, pooled, mutual and private client funds as a Vice President with Royal Bank Investment Management Inc., the fund management arm of the Royal Bank of Canada. She currently sits on the boards of a number of companies including Periowave Dental Technologies, Inc., OrGenX Biopharma Corp., and Sinuwave Technologies Corp, and sits on the Advisory Board of the McGill University Dental School. Ms Cross is a member of the Women’s Presidents Organization, the International Women’s Forum, the Toronto Society of Financial Analysts, the Courthill and Cherie Blair Foundations, and the Association for Professionals In Infection Control and Epidemiology. Ms Cross is the Founder of OrGenX Biopharma Corporation, a WEConnect certified company.
Follow Carolyn Cross:
About Ondine Biomedical: Ondine Biomedical develops non-antibiotic, anti-infective therapies for a broad spectrum of bacterial, viral, and fungal infections.
Alexandra Greenhill
Founder, CEO and CMO of Careteam Technologies
Alexandra is a physician leader turned tech entrepreneur, with a 15+ years track of record massive $100m+ healthcare innovations. Cofounded award-winning tech companies, is an EIR and a TedX speaker, Top 40 under 40, Most Influential Woman in STEM, WXN Most Powerful Woman and received the Queen Elizabeth II Medal of Service.
Follow Alexandra Greenhill:
About Careteam Technologies, myBestHelper, The Greenhill Group: Careteam Technologies develops a virtual care collaboration and communication platform.
Bruce Cazenave
CEO of Nautilus
Bruce Cazenave was appointed Chief Executive Officer and elected to our Board in May 2011. Bruce also served as our Acting Chief Financial Officer from July 3, 2013 until February 27, 2014. From January 2010 until his appointment as our Chief Executive Officer, Bruce served as managing director of Inflection Point Consulting, a business consulting firm, where he consulted with and served as an executive advisor to private equity firms in the U.S. and Europe. From 2006 to 2009, Bruce worked for Central Garden & Pet Company, a marketer and producer of quality branded products for the lawn and garden and pet supplies markets, serving as president of its Garden Décor Group. From January 2006 to August 2006, Bruce served as a strategy consultant to Timex Corporation, a watch manufacturer, where he focused on supply chain, operational and organizational priorities. From 2002 to 2005, Bruce served as President & CEO of Dorel Juvenile Group, a subsidiary of Dorel Industries, Inc. Dorel Juvenile Group is a marketer and manufacturer of juvenile products. Bruce has also served in senior executive roles at Black & Decker U.S., Inc. and Timberland – both in the U.S and Europe. Bruce is a graduate of John Hopkins University and received a Master’s degree from George Washington University. The Board has concluded that Bruce should continue serving as a director based on his over 20 years of senior executive leadership and extensive background running divisions of premier global consumer products companies focused on profitable growth.
Follow Bruce Cazenave:
About Nautilus: Nautilus markets a complete line of innovative health and fitness products through direct and retail channels.
Barry Allen
Founder,CEO & President of Calgary Scientific
CEO of PureWeb Inc. (Formerly Calgary Scientific Inc.), Co-Founder and Chairman of Zolo. Prior to founding Zolo, Barry was active in the VC and Start-up community as Entrepreneur In Residence for Ventures West, Creative Destruction Labs Vancouver and Calgary, Founder of BC Excels Program and Accredited Lead Mentor for BC Innovation Council. The majority of his career was spent building high tech public companies including building VSM MedTech from 2 employees to 200 and $360mm market cap on the TSX.
Follow Barry Allen:
About Calgary Scientific, Creative Destruction Lab (CDL), Zolo Realty: Calgary Scientific develops web and mobile diagnostic medical imaging solutions and collaboration enablement technologies.
Alistair Duncan
Co-Founder, President & CEO of viDA Therapeutics
Alistair Duncan, B.Sc., C.A. Co-founder of the Company in 2008 Alistair Duncan serves as President and Chief Executive Officer (CEO) of the Company. From 2009 to present, Alistair Duncan was co-founder, Director, and has served as interim Chief Financial Officer for Agrisoma Biosciences Inc., a company building a high performance crop seeds business for the development of new genetically modified crops for renewable fuels. From 1998 to 2008, Alistair Duncanwas President and CEO of Chromos Molecular Systems Inc., where he was also a co-founder and Director. Prior to that, he was a Principal with the Ernst & Young Corporate Finance and International Life Sciences Group where he provided high technology and life sciences companies with corporate advisory services in strategic planning, valuations, financing, divestitures, and mergers and acquisitions. Currently, Alistair Duncan also serves as a director on the board of Metro Vancouver Properties Corp. Alistair Duncan is a member of the Institute of Chartered Accountants of British Columbia and holds a B.Sc. in Biochemistry from the University of British Columbia.
Follow Alistair Duncan:
About viDA Therapeutics: viDA Therapeutics is a Canada-based biotech company that develops treatments for chronic inflammatory and age-related diseases.
Anton Solonnikov
Founder and CEO of VitaminLab
Anton Solonnikov is the Founder and CEO at VitaminLab.
Follow Anton Solonnikov:
About VitaminLab: VitaminLab creates an all-in one personalized supplement from your health data: health history, blood testing or health apps.
R. Lee Buckler
President & CEO, Director of RepliCel Life Sciences
Lee is Managing Director of and a consultant the Cell Therapy Group.Lee is the founder and managing director of Cell Therapy Group – a leading, boutique consultancy focused on the cell therapy and regenerative medicine industry.Through CTG Lee works with companies of all sizes to help position them in the cell therapy regenerative medicine space by focusing on business development including strategy development, competitive intelligence, market research and analysis, deal-making, marketing and communications, profile-building, sale-lead generation, etc. The core value Lee brings to CTG and its clients is a rare breadth of understanding of the entire spectrum of the cell therapy and regenmed industries primarily around who is doing what with whom. This knowledge of the industry players, what they have, and with whom they are working is both driven by and drives his proprietary industry database. Additionally, Lee leverages for his clients the relationships he has with executives in many of those companies. Since early 2000, Lee has been an executive in the cell therapy regenerative medicine industry. He has significant experience in both for-profit companies and non-profit organizations including Progenitor Cell Therapy, Malachite Management, Stem Cell Technologies, and the International Society for Cellular Therapy. Before transitioning to biotech, Lee earned a law degree (cum laude) and was a practicing commercial attorney for several years.Lee founded Cell Therapy News, created Cell Therapy Blog where he continues to blog, and serves on the Editorial Board of the journals BioProcess International and Regenerative Medicine. Lee founded and served as Chair of ISCT’s Cell Therapy Commercialization Committee (2006-9), founded and administers the LinkedIn Cell Therapy Industry Group, and has served as an advisor to dozens of groups and projects in the regenerative medicine space. He is a frequently invited speaker and moderator at conferences in the industry. Recent publications include a book chapter entitled, “State of the Regenerative Medicine Industry” in The Delivery of Regenerative Medicines and Their Impact on Healthcare (CRC Press) and “Opportunities in Regenerative Medicine: The Global Industry and Market Trends” in BioProcess International, March 2011 Supplement.
Follow R. Lee Buckler:
About RepliCel Life Sciences, Restructur Advisors: RepliCel Life Sciences is a regenerative medicine company using cell therapy products for healing tendinosis, aging, and pattern baldness.
Cindy Gu
Chief Executive Officer of VITALI Wear
Cindy received her formal education in Mechanical Engineering from the University of British Columbia, and has been fortunate enough to have studied Yoga and trained with the best. Her unconventional background combining the external creativity of engineering and the internal search of yoga and meditation led her to become an entrepreneur who defines her own path. As an engineer, yoga instructor and entrepreneur, the biggest problem she’s inspired to solve is the pandemic technology-drunkenness in modern lifestyle. She’s passionate about bridging technology and wellness together. Currently, she’s leading her start-up Vitali Wear to create next-generation of smart clothing for everyday wellbeing. Starting with breathing better, having better posture and becoming more mindful.
Follow Cindy Gu:
About VITALI Wear: VITALI Wear provides smart Apparels, bridging innovation and wellness through haptic wearable technology.
William Masih
CEO/Founder of Wellin5
William is the Founder and CEO of Wellin5, an innovative, confidential platform, which connects users with counsellors for secure audio-video online counselling. He is a visionary leader and tenacious advocate of living out health & wellness and building effective relationships.
His 15 years of experience managing large teams and his personal connection with counselling have inspired his journey in the mental health tech arena. William has been invited as a presenter and panellist to various tech health events across Canada and the U.S. representing Wellin5 as a technological solution for improving mental health. Presently he is focused on building Wellin5 to be one of the most technologically advanced solutions for online counselling through machine learning and AI.
Follow William Masih:
About Wellin5: Wellin5 is a one-stop solution to access online counseling & post-therapy support.
Doug Janzen
Chairman & CEO of Aequus Pharmaceuticals
Doug Janzen has been involved in the Life Sciences industry for the past 19 years. He is currently the Founder and President of Northview Ventures, an organization which invests in and provides strategic advisory services to a number of technology companies. Mr Janzen was part of the founding group of Aequus Pharmaceuticals. Previously, Mr Janzen was President and CEO of Cardiome Pharma, a NASDAQ listed drug development company that raised over $300 million from investors, and completed over $1 billion in licensing deals during his tenure. In 2010, Cardiome’s lead product, Brinavess, was approved and launched in Europe by Merck. Prior to that, he was an investment banker with Cormark Securities, acting as Managing Director of Life Sciences. Mr Janzen is Past Chair of LifeSciences BC, has served as a Director with Biotech Canada and currently sits as a Director on a number of public and private boards. He is a past winner of Business in Vancouver’s Top 40 Under 40 Award.
Follow Doug Janzen:
About Aequus Pharmaceuticals, Northview Ventures: Aequus Pharmaceuticals is a pharmaceutical company that focuses on therapeutic areas, including neurology, ophthalmology, and transplant.
Catherine Winckler
Founder and CEO of MindfulGarden Digital Health
Catherine Winckler currently works as Founder and Chief Executive Officer at Mindful Garden.
Follow Catherine Winckler:
About MindfulGarden Digital Health: MindfulGarden Digital Health develops a behaviour modification platform to de-escalate anxiety and aggression of patients with chronic disease.
Lukas-Karim Merhi
Founder & CEO of Tenzr Health
Lukas has four years of startup experience and is well network with VR|AR partners, R&D institutions and government funds. BIT is his second startup.
Follow Lukas-Karim Merhi:
About Tenzr Health: Technology-driven Motivation, Guidance, and Certainty for Musculoskeletal Care
Malcolm Kendall
CEO and Co-founder of Microbiome Insights Inc.
Malcolm Kendall has over 28 years of operational management, entrepreneurial, venture capital investment and leadership experience, the majority of which has been focused on company creation and building value in technology and biotechnology companies. Before founding Microbiome Insights, he was the co-founder and CEO of Indel Therapeutics Inc., a Vancouver-based biopharmaceutical company dedicated to developing new drugs to address the global health crisis caused by antibiotic resistance. Prior to this, Malcolm was an investment professional with life science focused venture capital firms MDS Capital (now Lumira Capital), BioVista Capital (now Hatteras Venture Partners) and Intersouth Partners. Before entering business, he served in the U.S. Army where he honed his leadership skills as an Infantry and Special Forces officer. Malcolm has been an advisor and board member to numerous companies and organizations and is currently a member of the board of directors of Semios BIO Technologies, a mentor for the entrepreneurship@UBC program and an adjunct professor at the MBA MOT program at Simon Fraser University. He received his undergraduate degree from Washington and Lee University and an M.B.A. from the Kenan-Flagler Business School at the University of North Carolina.
Follow Malcolm Kendall:
About Microbiome Insights Inc.: Microbiome Insights is a global leader providing end-to-end services for microbiome DNA sequencing and state-of-the-art bioinformatics.
Zeeshan Hayat
CEO of RxToMe
Follow Zeeshan Hayat:
About RxToMe: Prescription Delivery & Pharmacy Ecosystem
Harrison Brown
Co-Founder & CEO of HeadCheck Health
Harrison Brown is a Co-Founder and serves as Chief Executive Officer & Board Member at HeadCheck Health. He is the inventor, manager, and industry expert for the company. Harrison is a PhD candidate and Masters of Science graduate at UBC, he holds a Bachelor of Science degree from the University of Guelph, and has broad scientific research experience in sports-related concussion identification and management.
Follow Harrison Brown:
About HeadCheck Health: Software-as-a-Service (SaaS) concussion testing & compliance monitoring solution that works for any sports organization or clinic.
Allan Seckel
CEO of Doctors of BC
Allan was appointed Chief Executive Officer of Doctors of BC in October 2011. He began his career as a lawyer at Russell & DuMoulin, and was a partner of the merged firm of Fasken Martineau DuMoulin. In 2003, he started working for the provincial government as Deputy Attorney General, and later became the Deputy Minister to Premier Gordon Campbell and Head of the BC Public Service. In addition to a commerce and economics degree from SFU, Allan holds a Bachelor of Law from UVIC and a Master of Laws from Cambridge University. Allan serves on a number of boards, including Covenant House Vancouver and the TELUS Vancouver Community Board.
Follow Allan Seckel:
About Doctors of BC: Toolkit supports recruitment and retention efforts.
Geof Auchinleck
Co-Founder and CEO of Claris Healthcare
Geof Auchinleck has more than 35 years of experience in the medical device field. He was part of the Vancouver-based team that built and tested the world’s first robot specifically designed to assist in surgery, then went on to develop a number of other surgical technologies, including surgical tools for laparoscopic surgery, surgical limb positioning, blood sample handling equipment, apparatus for total knee arthroplasty, and surgical drapes. In 1997, Geof cofounded Neoteric Technology Ltd. Neoteric developed and commercialized technologies for ensuring the correct storage, tracking, handling and administration of blood for transfusion in hospitals. This technology, BloodTrack®, is now in daily use in hospitals all over the world. In 2009, Neoteric Technology Ltd. was acquired by Haemonetics Corporation of Braintree, Massachusetts (NYSE:HAE). Geof left Haemonetics in 2011.
Follow Geof Auchinleck:
About Claris Healthcare, Creative Destruction Lab (CDL): Claris Healthcare is medical technology company that provides SaaS Remote Patient Monitoring and Rehabilitation.
Lawrence Buchan
Chief Executive Officer of Arbutus Medical
BC Business 30under30 winner in 2020. Masters in biomed engineering from UBC. Orthopaedic research background. Held position as Director of Operations for Arbutus Medical from 2014-2018.
Follow Lawrence Buchan:
About Arbutus Medical: Simple orthopaedic power tools that save cost for hospitals.
Sandra Milne
CEO and Owner of Action Industrial First Aid
Sandra is the longest-term Actionite in the building and as a self-proclaimed commitment-phobe’, she’s pretty proud of what’s been accomplished during her tenure. “Six-years!” she laughs about her longevity with Action. “That’s a record. Who knew when I joined the team in 2005 that I’d like the company so much… I’d buy it?” When asked what she liked so much about Action Health & Safety Services, she’s quick to answer, “I was diagnosed with ADD as an adult and as such I’m not organized. Being around me is often chaotic and if I’m not learning, I’m stagnating.” Sandra added she thrives on constant challenge. “It is ever changing, dynamic, never, ever, boring!”
Follow Sandra Milne:
About Action Industrial First Aid: Action Industrial First Aid is a provider of professional first aid, safety and security services.
Frederick Sancilio
Chairman, President and CEO of Sancilio and Company
Frederick D. Sancilio is the Principle and Co-Founder of Sancilio and Company.
Follow Frederick Sancilio:
About Sancilio and Company: Sancilio and Company develops biopharmaceutical supplements and products.
Jessica Yang
Co-founder & CEO of Tochtech
Follow Jessica Yang:
About Tochtech: Tochtech is a healthcare technology on a mission to apply innovations for Seniors daily living.
Aldar Bourinbaiar
CEO of Immunitor
Aldar Bourinbaiar is the CEO at Immunitor.
Follow Aldar Bourinbaiar:
About Immunitor: Immunitor develops orally-delivered immunotherapies for a number of serious diseases affecting the world.
Sean Sibbet
CEO of Reality Controls Inc.
Follow Sean Sibbet:
About Reality Controls Inc.: Contract developer of custom software applications for health and security, on IoT, mixed/virtual reality and cloud data platforms.
Behzad Behroozan
Founder and CEO of Agartee Technology Inc.
Follow Behzad Behroozan:
About Agartee Technology Inc.: Agartee Vibe System is designed to track and monitor sleep and daily activities to ensure the user is maintaining a healthy lifestyle.
GIPHY App Key not set. Please check settings